KIR3DL2 and COVID-19: Similarly, the frequency of the KIR3DL2+HLA-A3+ combination (11.5 vs. 26.1%, p = 0003, OR = 0.37, CI = 0.21–0.63) was significantly lower in COVID-19 patients than in the general population controls.